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Background: Common mental disorders (CMD) have a major impact on both society and 
individual workers, so return to work (RTW) is an important issue. In The Netherlands, the 
occupational physician plays a central role in the guidance of sick-listed workers with respect to 
RTW. Evidence-based guidelines are available, but seem not to be effective in improving RTW 
in people with CMD. An intervention supporting the occupational physician in guidance of sick-
listed workers combined with specific guidance regarding RTW is needed. A blended E-health 
module embedded in collaborative occupational health care is now available, and comprises 
a decision aid supporting the occupational physician and an E-health module, Return@Work, 
to support sick-listed workers in the RTW process. The cost-effectiveness of this intervention 
will be evaluated in this study and compared with that of care as usual.
Methods: This study is a two-armed cluster randomized controlled trial, with randomization 
done at the level of occupational physicians. Two hundred workers with CMD on sickness 
absence for 4–26 weeks will be included in the study. Workers whose occupational physician 
is allocated to the intervention group will receive the collaborative occupational health care 
intervention. Occupational physicians allocated to the care as usual group will give conventional 
sickness guidance. Follow-up assessments will be done at 3, 6, 9, and 12 months after baseline. 
The primary outcome is duration until RTW. The secondary outcome is severity of symptoms 
of CMD. An economic evaluation will be performed as part of this trial.
Conclusion: It is hypothesized that collaborative occupational health care intervention will 
be more (cost)-effective than care as usual. This intervention is innovative in its combination 
of a decision aid by email sent to the occupational physician and an E-health module aimed at 
RTW for the sick-listed worker.
Keywords: design protocol, randomized controlled trial, common mental disorders, sickness 
absence, return to work, blended E-health
Introduction
Suffering from a common mental disorder (CMD) affects many aspects of life, including 
work participation and functioning.1 In The Netherlands, mental health problems 
account for one third of all disability benefits.2 Mental health problems are also strongly 
associated with long-term sickness absence, ie, an estimated 10.5 extra absence days 
per year.3 Although long-term sickness absence constitutes only a small fraction of 
all absence episodes, it comprises more than a third of total days lost and up to 75% 
of all absence costs.4 Along with the substantial costs incurred by sickness absence, 
the worker’s quality of life is also affected by long-term sickness absence.4 A survey 
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has shown that the ability to work is an important aspect 
of quality of life.5 Prolonged absence from work increases 
the risk of isolation and reduces meaningful activity, and 
workers may become anxious about return to work (RTW), 
doubting their competency and fearing the reactions of 
coworkers. Therefore, considering the implications for the 
worker’s quality of life and the massive costs incurred by 
sickness absence, improving the process of RTW for people 
with CMD is important.4,6 However, the studies reported to 
date have shown that although evidence-based guidelines 
do exist for occupational physicians,7 and the Gatekeeper 
Improvement Act was established in The Netherlands to 
make both employer and worker responsible for RTW, the 
guidelines are insufficiently followed8–14 and occupational 
physicians often lack the time and skills to deal with sick-
listed workers with CMD.
For a number of years, the assumption was that recovery 
of function would follow automatically after recovery of 
symptoms, but a Cochrane review and more recent studies 
show that reduction of symptoms does not automatically 
lead to RTW.15–18 Moreover, during regular psychological 
treatment by a general practitioner or a mental health 
specialist, there is a need for more focus on work-related 
topics.19,20 To avoid long-term sickness absence, the Dutch 
guideline for psychologists states that RTW needs to be an 
important aspect of treatment.21 However, Oomens et al 
reported that the guideline was not used effectively and that 
RTW was often not addressed.22
Several studies have been performed recently to improve 
RTW of workers with CMD. A study of psychiatric 
consultations among Dutch occupational physicians, with a 
focus on work issues and RTW, found some improvement 
with respect to RTW.23 A more extended model of this 
intervention is collaborative care, that requires monitoring 
by a care manager.24–26 In the Dutch setting, a collaborative 
care model in the occupational health setting, in which 
one occupational physician provided treatment of major 
depressive disorder and another occupational physician 
provided regular monitoring of work absence, showed 
short-term improvement of depressive symptoms and a 
slight, but statistically insignificant, improvement in terms of 
RTW.27–29 These modest results may reflect implementation 
problems, indicating that better results could be expected if 
the intervention was better implemented.
Other studies have suggested that RTW interventions 
should be carried out close to the workplace.15,17 Workplace 
interventions can be considered to be a form of disability 
management for the individual worker that facilitates RTW 
by removing barriers to returning to the workforce.30 A review 
of the effectiveness of workplace interventions could not 
draw convincing conclusions for CMD due to a lack of 
studies. However, this review did conclude that it is important 
that all relevant stakeholders facilitate RTW.30
A recent review suggested that, in addition to intervening 
on severity of the disorder during guidance for sick-listed 
employees, it is important that personal factors like self-
efficacy and intention to RTW despite having symptoms 
receive extra attention when designing interventions.1,31 
A prospective study exploring factors related to self-efficacy 
in RTW showed that, along with health-related factors, the 
attitude regarding RTW with symptoms is also important.32 
This suggests that, in order to achieve a more rapid and lasting 
RTW for workers with CMD, a focus on both symptoms 
and RTW, with a special focus on cognitions regarding 
RTW while having symptoms, is recommended. Therefore, 
a collaborative care model with the possibility of psychiatric 
consultation should be combined with a specific approach 
aimed at RTW.
In the current study, an intervention known as the 
“E-health module embedded in Collaborative Occupational 
Health Care” (ECO) is being evaluated. ECO is a blended 
E-health intervention aimed at RTW. ECO comprises a 
decision aid sent by email supporting the occupational 
physician and a separate E-health module for the sick-listed 
worker, both of which were developed for this study. The 
decision aid will support occupational physicians in the 
guidance of sick-listed workers with CMD and includes 
elements of collaborative care, such as continuous monitoring 
of progress and access to psychiatric consultation. The 
E-health module, known as “Return@Work”, for sick-listed 
workers gives information and homework, and focuses on 
the importance of work for people with CMD and their 
perceptions regarding RTW with symptoms.
This paper describes the design of a cluster randomized 
controlled trial in which the cost-effectiveness of the 
Return@Work intervention combined with collaborative care 
(ECO) is compared with that of care as usual in sick-listed 
workers with CMD. The study protocol was approved by 
the medical ethics committee at the Institutions for Mental 
Health, Utrecht, The Netherlands, in February, 2011.
Materials and methods
Objectives
The primary aim of this randomized controlled trial is to 
evaluate the effectiveness of ECO intervention versus care 
as usual in terms of time to RTW. Time to RTW is defined 
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as the duration of sickness absence in calendar days, from 
the day of randomization until the first RTW in own or 
other work with equal earnings for at least 4 weeks without 
recurrence. The secondary aim is to evaluate the effectiveness 
of the ECO intervention in terms of response and remission 
of depressive symptoms. Third, the cost-effectiveness of the 
ECO intervention will be evaluated, and includes both direct 
and indirect costs.
study design
This study is a two-armed cluster randomized trial. Cluster 
randomization will occur at the level of occupational 
physicians in order to prevent contamination and dilution of 
the effect of intervention. Occupational physicians working in 
the same region will be clustered, because they would take over 
each other’s work in the event of a vacation or an emergency. 
Occupational physicians allocated to the intervention group 
will receive training in ECO, ie, the principles of the decision 
aid and in following up on the recommendations derived 
from the E-health module for workers, ie, Return@Work. 
Workers whose occupational physicians are allocated to the 
intervention group will receive the ECO intervention, ie, 
they will receive guidance from their occupational physician 
and will work through the E-health Return@Work module. 
Occupational physicians allocated to the care as usual group 
will not receive training or get the decision aid, nor will 
their workers get access to Return@Work. The intervention 
cannot be blinded because the occupational physicians and 
their patients would be aware of their group allocation. This 
is common in psychiatric intervention research and several 
approaches can be taken to diminish possible bias.50 Patient 
data will be obtained from self-reported questionnaires and 
registers held by the occupational health service and insurance 
company in order to exclude the possibility of interviewer 
bias. Figure 1 shows a flow chart for the participants.
Recruitment of occupational physicians
The occupational physicians will be recruited in collaboration 
with Arbo Vitale, a large occupational health service, and 
GGzBreburg a large mental health service employer, both in 
The Netherlands. Occupational physicians identified by Arbo 
Vitale and GGzBreburg and allocated to the intervention 
group will receive training in ECO before the workers are 
approached.
Recruitment of patients
The study will focus on workers with CMD who are on 
sickness absence for 4–26 weeks. A minimum of 4 weeks of 
sickness absence was chosen to avoid including patients with 
spontaneous recovery. The participants are to be recruited in 
collaboration with Arbo Vitale and GGzBreburg. Arbo Vitale 
is an occupational health service for employees in small-sized 
to medium-sized companies, whose employers are insured 
for the costs of sick leave and sickness guidance.
First, all workers sick-listed for 4–26 weeks will receive 
written information about the study from their occupational 
health service (Arbo Vitale) or employer (GGzBreburg), 
a letter from the occupational health service or employer, 
together with an information leaflet from the Trimbos 
Institute, an informed consent form, and a short screening 
instrument for depression, anxiety, and somatization. The 
depression and somatization subscales of the Patient Health 
Questionnaire (PHQ) will be used, ie, PHQ-9 for depression 
and PHQ-15 for somatization, and the Generalized Anxiety 
Disorder (GAD-7) scale for anxiety. These instruments 
have shown good psychometric properties for screening of 
depression, anxiety, and somatization.33–35 The workers are 
asked if they are willing to participate in a study investigating 
guidance for sick-listed workers with CMD. If they agree, 
they will be asked to sign the informed consent form and 
to return it to the researchers, together with the completed 
screener. In the information leaflet, it is emphasized that 
participation in the study is voluntary and that refusal to 
participate will not have consequences for their (future) 
guidance and sickness certification. Scores on the PHQ-9, 
GAD-7, and PHQ-15 will then be calculated for workers who 
return the screening questionnaires and give their informed 
consent. Workers will be considered screen-positive if they 
score $ 10 on one of the three questionnaires. These workers 
will be contacted by telephone.
The telephone conversations will be conducted by trained 
research assistants who are blinded to the randomization 
scheme. The research assistants will check for inclusion 
and exclusion criteria and give information about the study. 
Sick-listed workers who do not meet any of the exclusion 
criteria will receive the baseline questionnaire and a 
second informed consent form. Workers who complete 
the questionnaire and give their informed consent will be 
included in the study. Workers in the intervention group will 
be sent a login code for the Return@Work intervention.
Exclusion criteria
Workers with insufficient knowledge of the Dutch language 
and those who are pregnant will be excluded from the study. 
Workers involved in legal action against their employer, eg, 
because of a conflict at work, will also be excluded.
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Training
Prior to starting the intervention, the occupational physicians 
allocated to the intervention group will receive training in ECO. 
The training will focus on sickness guidance for sick-listed 
workers with CMD, working with the decision aid, and contact 
with other stakeholders in the RTW process. As mentioned 
earlier, the guidelines for occupational physicians on guidance 
and treatment of sick-listed workers with CMD are insuffi-
ciently followed. The decision aid will help the occupational 
physicians to guide the worker according to the guideline and 
will give specific stepped-care treatment suggestions. During 
training, the occupational physicians will also be encouraged to 
contact other key stakeholders in the RTW process. In the event 
of stagnation, the occupational physician is required to contact 
other health care providers from whom the worker receives 
treatment, and discuss other treatment options according to 
the stepped-care advice outlined in the decision aid. Another 
important stakeholder is the employer, and the decision aid will 
advise occupational physicians to involve the employer in the 
RTW process and conduct a workplace intervention as defined 
by the STECR guideline if necessary.36 This training will be 
conducted by the researchers and a psychiatrist.
Guidance in intervention group
Return@Work aimed at RTW  
for sick-listed workers
The worker will receive an individual login code for 
the E-health RTW module, which is placed on a secure 
website. Through Return@Work, workers will receive 
information and homework assignments. They work 
Workers of these OPs who are
sick listed between 4 and 26
weeks are approached
Telephone conversation:
check of exclusion criteria
Excluded
– No response
– Negative screener 
   (=PHQ-9 < 10, PHQ-15
   < 10 and GAD-7 < 10)
Screening:
PHQ-9, PHQ-15, GAD-7
1st informed consent
ECO intervention CAU
Clusters of OPs randomized in ECO
intervention or CAU
Baseline (T0) questionnaire
2nd informed consent
Excluded
– Language problems
– Pregnant 
– Legal involvement with
   employer 
T1 questionnaire
(3 months)
T1 questionnaire
(3 months)
T2 questionnaire
(6 months)
T2 questionnaire
(6 months)
T3 questionnaire
(9 months)
T3 questionnaire
(9 months)
T4 questionnaire
(12 months)
T4 questionnaire
(12 months)
No response
T2
No response
T2
No response
T3
No response
T4
No response
T1
No response
T1
No response
T3
No response
T4
Workers of these OPs who are
sick listed between 4 and
 26 weeks are approached
Telephone conversation:
check of exclusion criteria
Screening:
PHQ-9, PHQ-15, GAD-7
1st informed consent
Baseline (T0) questionnaire
2nd informed consent
Excluded
– No response
– Negative screener
   (= PHQ-9 < 10, PHQ-15
   < 10 and GAD-7 < 10)
Excluded
– Language problems
– Pregnant 
– Legal involvement with
   employer 
Figure 1 Flow chart of participants. 
Abbreviations: OP, occupational physician; CAU, care as usual; PHQ-9, Depression scale of the Patient Health Questionnaire; PHQ-15, somatization scale of the Patient 
Health Questionnaire; GAD-7, Generalized Anxiety Disorder scale.
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through Return@Work individually, but workers are free 
to discuss topics or assignments with their occupational 
physicians. In that case, workers can print down specific 
pages in the module. The symptoms, functioning, and 
RTW of the worker are monitored in Return@Work on 
a regular basis. Workers can choose whether they want 
to have their monitor outcomes sent to the occupational 
physician. As in usual sickness guidance, the occupational 
physician and worker meet with each other face-to-face on 
a regular basis. The occupational physician cannot login 
to the worker’s E-health module, but can inquire about the 
worker’s progress in Return@Work and ask whether the 
worker needs support.
The content of Return@Work is tailored to the needs of 
workers. The content depends on the worker’s symptoms 
and perceptions about RTW. Return@Work begins with 
a baseline measurement, which includes questions about 
symptoms, functioning, and cognitions about RTW. The 
worker will receive the elements of Return@Work that best 
fit their symptoms. Return@Work includes the following 
elements:
•	 Psychoeducation.
•	 A module aimed at perceptions with regard to RTW 
while having symptoms, based on cognitive-behavioral 
principles.
•	 A module containing problem-solving treatment 
exercises, aimed at clearly defining problems and 
goals, learning and applying problem-solving skills, 
and developing more control in problem situations. The 
worker learns how to formulate practical ways of dealing 
with problems.37 In Return@Work, the problem-solving 
treatment focuses on the problems the worker encounters 
in the process of RTW.
•	 A module for pain and fatigue management and for 
reactivation.
•	 A module for relapse prevention, facilitating the worker 
in identifying a list of risk factors for situations increasing 
the likelihood of recurrence of loss of control, as stated 
by The Netherlands Society of Occupational Medicine 
guideline.7
•	 Continuous monitoring of functioning (including RTW), 
symptoms, and defining personal goals. The workers 
will be monitored with the questionnaire that best fits 
their symptoms. This is the PHQ-9 for workers with 
predominantly depressive symptoms, GAD-7 for workers 
with anxiety symptoms, and PHQ-15 for workers with 
somatization. The Sickness Impact Profile will be used 
to monitor functioning in multiple aspects.38
Decision aid sent by email to occupational  
physician to guide sick-listed workers
The email messages include a decision aid and is based on 
principles of stepped collaborative care. The decision aid 
assists the occupational physician in guiding the sick-listed 
worker, monitoring of symptoms, functioning, and RTW. 
As noted earlier, the symptoms, functioning, and RTW of 
the worker will be regularly assessed in the Return@Work 
module. If the worker consents to their monitor outcomes 
being sent to the occupational physician, these are used in 
email messages for the occupational physician to give advice 
tailored to the individual worker. If the worker does not give 
permission to send monitor outcomes from Return@Work 
to the occupational physician, the email message gives more 
global information. In addition to specific stepped-care treat-
ment suggestions that the decision aid gives in the email 
messages, it will also urge the occupational physician to 
involve the employer in the RTW process and to conduct a 
workplace intervention as defined by the STECR guideline 
if necessary.36 Further, the occupational physician will have 
access to a consultant psychiatrist who, when needed, gives 
advice in the event of stagnation.
Guidance in control group
The occupational physicians in the control group will not 
receive training in ECO, and will instead provide usual 
guidance to their sick-listed workers. Care as usual will be 
delivered according to the guidelines of the Dutch Board for 
Occupational Medicine.7
Data collection
The study data will be collected by The Netherlands Institute 
of Mental Health and Addiction. Patients will be sent ques-
tionnaires and asked to participate in the study and provide 
their written informed consent. Measurement will be done at 
baseline (T0), and at 3 (T1), 6 (T2), 9 (T3), and 12 months 
(T4) after entry to the study. The questionnaires should be 
completed on the Internet and will be processed automati-
cally and anonymously. Data about RTW will also be derived 
from registers held by the occupational health service and 
the insurance company.
Primary outcome measure
The primary outcome measure is RTW, defined as the duration 
of work absence due to CMD in calendar days, from the day 
of randomization until the point of first partial RTW in own or 
equal work with equal earnings, for at least 4 weeks without 
relapse. Data will be derived from the sick leave databases 
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of the occupational health service, the insurance company, 
and GGzBreburg. Missing or incomplete data will be derived 
from the second part of the Trimbos/iMTA questionnaire for 
Costs associated with Psychiatric Illness (TiC-P), ie, on the 
short form of the Health and Labor Questionnaire (SF-HLQ), 
with an added question asking explicitly about RTW.39,40 
The full RTW will be analyzed separately in the secondary 
analysis. Presenteeism, as assessed by the TiC-P, will also 
be taken into account.
secondary outcome measures
The secondary outcome measures are the severity of 
depressive, anxiety, and somatization symptoms, as measured 
with the PHQ-9, GAD-7, and PHQ-15,33–35 respectively. 
Response is defined as a 50% reduction in symptoms. 
Another secondary outcome measure is remission, defined 
as a score lower than 5.
Tertiary outcome measure
The tertiary outcome is the cost-effectiveness of ECO 
compared with care as usual. The economic evaluation will 
be performed from a societal perspective, including direct 
and indirect costs. A cost minimization analysis will be used 
to identify differences in costs of ECO versus care as usual 
by quantification of productivity losses. The Trimbos/iMTA 
questionnaire for TiC-P is used for calculating costs.40 The 
TiC-P consists of two parts. The first part collects data on 
medical consumption. The second part of the TiC-P, the 
SF-HLQ, is used for collecting data on productivity costs 
due to absence from work and reduced efficiency.39
Health care costs
Health care costs for the participants will be collected over a 
12-month period, starting from the date of inclusion. Because 
mental health problems may affect both physical and mental 
functioning, all health care-related costs will be collected dur-
ing follow-up. Calculating the total direct medical costs, the 
total number of medical contacts (eg, outpatient visits, hospital 
length of stay, use of medication) will be multiplied by the unit 
costs of the corresponding health care services. Reference unit 
prices of health care services will be applied and adjusted to 
the year of this study using the consumer price index.
Productivity costs
The cumulative number of sickness absence days during 
a one-year follow-up will be used. Costs associated with 
productivity loss will be calculated by the friction cost 
method and human capital approach. Using the friction cost 
method, productivity losses are limited to the time needed to 
restore production back to its initial level. This means that the 
friction cost method is the estimated time it takes a company 
to find a replacement for the sick worker. Productivity loss 
costs using the friction cost method will be estimated by 
multiplying the average daily wage by the gross number of 
sickness absence days up to a standard friction cost period. 
Productivity loss costs using the human capital approach 
will be estimated by multiplying the average daily wage by 
the total gross number of sickness absence days, using the 
entire period of sickness absence.
Additional outcome measures
The worker’s self-efficacy with regard to RTW and barriers to 
and facilitators of RTW will be measured using 14 questions 
on a 5-point Likert scale.41 Quality of life will be measured 
using the EuroQol42 and the Short-Form-36,43 both of which 
are validated instruments for measuring general health-
related quality of life. Six scales of the Sickness Impact 
Profile will be used to measure functioning in life areas 
such as social interactions, and work and leisure time.38 
Patient satisfaction with the occupational physician will be 
assessed using the Patient Satisfaction with Occupational 
Health Questionnaire.44 Physical symptoms are measured by 
the Physical Symptom Questionnaire.45 Further, the Whitely 
index will be used to measure attitude towards illness.46
Age, gender, nationality, marital status, living situation, 
and education will be measured at baseline. Comorbid 
chronic medical illness will be measured using a 28-item 
questionnaire developed by the Dutch Central Department 
of Statistics. Job characteristics will be measured by the Job 
Content Questionnaire at baseline.47 Neuroticism will be 
measured at baseline using the neuroticism scale of the NEO 
Five-Factor Inventory.48
Power calculations
A power calculation was performed on the primary outcome 
measure of time to RTW. In order to calculate the sample size, 
a hazard ratio of 1.6 was assumed as the smallest clinically 
and societally relevant ratio. A hazard ratio of 1.6 indicates 
that workers in the intervention group return to work about 
1.5 times more quickly than workers in the care as usual 
group. This hazard ratio is based on recent studies of RTW 
and on preliminary results from a pilot randomized controlled 
trial in a population of workers on sick leave because of 
CMD, in which workers returned to work at 122 days, 
being 68 days earlier after receiving an intervention with 
collaborative care than after care as usual.23 Based on the 
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assumed hazard ratio of 1.6, the calculation showed that a 
sample size of 160 completers would be needed. Because 
multilevel analysis will be performed, this number will 
be multiplied by a factor of 1.25 to account for possible 
intraclass correlation. Therefore, 200 completers will be 
needed.49 Noncompleters are not expected in the primary 
outcome, because data for time to RTW will be derived from 
the sick leave databases of the occupational health service, 
the insurance company, and GGzBreburg.
The duration of the study will be 4 years, with a 
preparation phase of one year. The inclusion phase will last 
1.5 years. Follow-up points will be at 3, 6, 9, and 12 months 
after inclusion, which takes one year. Data analyses will take 
6 months. This study was initiated in 2010 and the results 
are expected in 2014.
statistical analysis
All analysis will be conducted according to the intention-to-
treat principle. Multilevel analysis will be performed using 
clusters of occupational physicians at the first hierarchical 
level and individual participants at the second level. The 
Cox proportional hazards model will be used to derive the 
hazard ratio for RTW rates. Evaluation of the effectiveness 
of intervention will be performed with two-tailed tests at a 
significance level of 5%. The analyses will be controlled for 
duration of sickness absence at baseline. If differences in RTW 
are indeed found between the two experimental conditions, the 
cost differences due to productivity loss because of differences 
in RTW will be reported in a cost minimization analysis. 
Further, the 95% confidence intervals for the differences in 
mean costs in both groups will be computed by bias correction 
and accelerated bootstrapping with 2000 replications. In the 
event of missing data on costs, and any additional uncertainty 
introduced, we will use multiple imputation. Further, we 
will investigate if there are any differences in the effects of 
intervention for workers included by the occupational health 
service (Arbo Vitale) or their employer (GGZBreburg).
Discussion
The basis for this study is the large burden of CMD on the 
level of sickness absence for society as well as for individual 
workers, and the substantial costs involved. The aim of the 
study is to achieve an earlier and durable RTW and to reduce 
the symptoms of CMD.
Comparison with other studies
The ECO is aimed at RTW and comprises a decision 
aid communicated via email to support the occupational 
physician and a separate E-health module for the sick-listed 
worker, both were developed for this study. The decision 
aid will support occupational physicians when guiding 
sick-listed workers with CMD, and will include elements 
based on collaborative care, such as ongoing monitoring 
of progress and access to psychiatric consultation. A 
collaborative care model for major depressive disorder in 
the occupational health setting was recently investigated 
and showed limited results in terms of RTW, probably as a 
result of implementation problems.27–29 The authors stated that 
there would be a need to operationalize collaborative care 
differently in the occupational health care setting in future 
studies. The dual focus on RTW and depressive symptoms 
remains important, but it is not advisable to combine both 
strategies in one intervention delivered by one occupational 
physician.27–29 In the present study, the role of the occupational 
physician is to refer and monitor the efficacy of treatment and 
to improve collaboration between occupational physicians 
and the curative health sector.
The E-health module, Return@Work, provides 
information and homework for sick-listed workers, and 
focuses on the importance of work for people with CMD 
and their perceptions regarding RTW while still having 
symptoms. This is in line with the conclusions of several 
studies, ie, in addition to intervening on the severity of the 
disorder when guiding sick-listed employees, it is important 
that personal factors, such as self-efficacy and intention to 
RTW despite having symptoms, receive attention.1,31
Several studies have shown that it is important to increase 
the focus on graded activity and workplace interventions 
aimed at RTW. Return@Work focuses on RTW and on 
motivating the worker.15,16 The decision aid advises the 
occupational physician to involve the employer in the 
RTW process and to conduct a workplace intervention if 
necessary.
strengths and limitations
This study is innovative in its combination of a decision aid 
by email for the occupational physician with the possibility 
of consulting a psychiatrist and an E-health module aimed at 
RTW for the sick-listed worker. Effective elements of other 
studies have been brought together in this study. Therefore, 
it is anticipated that ECO will reduce symptoms and sick 
leave, and decrease the associated costs.
A potential limitation of this study is that the study design 
does not allow inferences to be made about the effectiveness 
of the different components of ECO (a decision aid sent by 
email to the occupational physician or the e-health module 
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Return@Work for the sick-listed worker), but only about the 
(cost)-effectiveness of the whole intervention. Further, at the 
screening stage, workers will be asked if they are willing to 
participate in the study, which may introduce a self-selection 
bias in the sense that those who are better motivated may be 
more likely to participate. However, if ECO proves to be 
effective and is implemented, employees will also be asked 
if they want to participate, because their engagement will be 
needed. In this way, the outcomes of the study will reflect 
daily practice, which will make the results of this study 
more generalizable to daily practice. A strength of the study 
design is that the intervention has a strong focus on RTW in 
addition to symptoms and involves the sick-listed worker as 
well as the occupational physician in the intervention. If the 
intervention proves to be (cost-)effective in the guidance of 
sick-listed workers with CMD, wider implementation would 
be considered, given the impact of CMD and long-term 
sickness absence on the individual worker and society.
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